Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-06-15
著者
-
Wang Hao
Clinical Neuroscience And Pain Johnson & Johnson Pharmaceutical Research And Development
-
JIAN Wenying
Bioanalysis/DMPK, Johnson & Johnson Pharmaceutical Research and Development
-
EDOM Richard
Bioanalysis/DMPK, Johnson & Johnson Pharmaceutical Research and Development
-
WENG Naidong
Bioanalysis/DMPK, Johnson & Johnson Pharmaceutical Research and Development
-
ZANNIKOS Peter
Clinical Pharmacology, Johnson & Johnson Pharmaceutical Research and Development
-
ZHANG Zhiming
Analgesics Team, Johnson & Johnson Pharmaceutical Research and Development
-
Edom Richard
Bioanalysis/dmpk Johnson & Johnson Pharmaceutical Research And Development
-
Weng Naidong
Bioanalysis/dmpk Johnson & Johnson Pharmaceutical Research And Development
-
Jian Wenying
Bioanalysis/dmpk Johnson & Johnson Pharmaceutical Research And Development
-
Zhang Zhiming
Analgesics Team Johnson & Johnson Pharmaceutical Research And Development
-
Zannikos Peter
Clinical Pharmacology Johnson & Johnson Pharmaceutical Research And Development
関連論文
- Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma
- Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites